Æterna Zentaris, Inc.
(Toronto Stock Exchange : AEZS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.90%128.130.0%$857.95m
AMGNAmgen, Inc. 0.39%250.021.5%$847.94m
GILDGilead Sciences, Inc. 0.13%63.741.0%$544.87m
VRTXVertex Pharmaceuticals, Inc. -1.33%264.771.9%$479.96m
REGNRegeneron Pharmaceuticals, Inc. -1.65%670.672.6%$430.87m
ILMNIllumina, Inc. -2.09%239.953.3%$317.73m
NVAXNovavax, Inc. -8.54%47.0175.7%$267.19m
BIIBBiogen, Inc. -1.03%197.351.8%$234.42m
BNTXBioNTech SE -4.60%155.710.0%$215.91m
EXASEXACT Sciences Corp. -4.33%49.7517.7%$136.76m
SNSSSunesis Pharmaceuticals, Inc. -7.62%1.940.7%$135.61m
TECHBio-Techne Corp. -1.93%357.474.5%$101.66m
NKTXNkarta, Inc. -5.95%12.010.0%$99.01m
BMRNBioMarin Pharmaceutical, Inc. -0.95%79.604.2%$98.57m
TXG10X Genomics, Inc. -6.79%46.380.0%$95.92m

Company Profile

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.